Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Nouveau
AddedFeb 17, 2024
UpdatedJun 18, 2026
Nouveau

Nouveau

Seed

NouvEau, a private R&D firm, creates patented health products from wine, including a unique 30:1 concentrate.

HQ
Lafayette, IN, US
Founded
2004
Overview
Compare
Fundraising
Employees
Website

NouvEau, founded as a private entrepreneurial research and development firm, focuses on creating innovative health products derived from wine. Its core mission is to leverage advanced scientific methods to transform wine by-products into valuable health solutions, with a vision to revolutionize the health and wellness industry. NouvEau's flagship product is a patented 30:1 wine concentrate enriched with functional ingredients like Vitamin B. The company aims to demonstrate its technology through commercial proof of concept, seeking to license or sell its intellectual property and products.

NouvEau boasts a portfolio of notable intellectual properties, including U.S. patents for by-products from fermentation still bottoms and pending patents for wine health mixtures. The company holds trademarks such as "Eau de Vin" in both the U.S. and internationally. Through its innovative approach and robust IP portfolio, NouvEau has made significant strides in the health product market, demonstrating the potential to impact the industry by offering unique, scientifically-backed health solutions.

Nouveau - Similar Companies

Brand New Brands logo

Brand New Brands

Nouvre logo

Nouvre

Novogiene logo

Novogiene

Fresh Vine Wine logo

Fresh Vine Wine

freshvinewine.com

Purewine logo

Purewine

drinkpurewine.com

Vinomis Laboratories logo

Vinomis Laboratories

Nomva logo

Nomva

Liquid Health Labs logo

Liquid Health Labs

Novos logo

Novos

novoslabs.com

Nouera logo

Nouera

Healthvice logo

Healthvice

Dionysus Technology Concepts logo

Dionysus Technology Concepts

Nuveta logo

Nuveta

nuveta.com

Novela Neurotech logo

Novela Neurotech

novelaneuro.com

The Wine Noire logo

The Wine Noire

thewinenoire.com

Nouveau - Quick Facts

Who are Nouveau's competitors?

Companies similar to Nouveau include Brand New Brands, Nouvre, Novogiene and Fresh Vine Wine.

When was Nouveau founded?

Nouveau was founded in 2004.

Where is Nouveau's headquarters located?

Nouveau's headquarters is located in Lafayette, IN, US.

When was Nouveau's last funding round?

Nouveau's most recent funding round was for $12k (USD) in January 2015.

How much has Nouveau raised to-date?

As of Jan 27, 2015, Nouveau has raised a total of $12k (USD).

How many employees does Nouveau have?

Nouveau has 38 employees as of Feb 4, 2024.

Nouveau - Classification

Geographic Exposure
  • United States
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Health Products
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 3 more industry codes
NAICS
  • 310000Manufacturing
  • 311000Food Manufacturing
SIC
  • 2000Food And Kindred Products